• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

10.42 +0.02 (+0.19%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,301,340
Open 10.40
Bid (Size) 10.42 (200)
Ask (Size) 10.57 (2,000)
Prev. Close 10.40
Today's Range 10.28 - 10.49
52wk Range 4.720 - 19.11
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off
November 09, 2025
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
3 Volatile Stocks We Keep Off Our Radar
November 06, 2025
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory

Performance

YTD
-36.8%
-36.8%
1 Month
+11.6%
+11.6%
3 Month
+71.4%
+71.4%
6 Month
+24.6%
+24.6%
1 Year
-36.3%
-36.3%

More News

Read More
NeoGenomics to Participate in Upcoming Investor Conferences
November 06, 2025
From NeoGenomics, Inc.
Via Business Wire
The Top 5 Analyst Questions From NeoGenomics’s Q3 Earnings Call
November 04, 2025
Via StockStory
Topics Earnings
Earnings Scheduled For October 28, 2025
October 28, 2025
Via Benzinga
NeoGenomics (NEO): Buy, Sell, or Hold Post Q3 Earnings?
November 03, 2025
Via StockStory
Topics Stocks
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
October 30, 2025
From NeoGenomics, Inc.
Via Business Wire
NEO Q3 Deep Dive: Clinical Volume Gains and New Product Launches Shape Outlook
October 29, 2025
Via StockStory
NeoGenomics (NEO) Q3 2025 Earnings Call Transcript
October 28, 2025
Via The Motley Fool
Topics Earnings Intellectual Property
Why NeoGenomics (NEO) Stock Is Trading Up Today
October 28, 2025
Via StockStory
Topics World Trade
NeoGenomics Inc (NASDAQ:NEO) Surpasses Q3 Revenue Estimates as Clinical Testing Drives Growth
October 28, 2025
Via Chartmill
Topics Earnings
NeoGenomics’s (NASDAQ:NEO) Q3 Sales Top Estimates, Stock Soars
October 28, 2025
Via StockStory
NeoGenomics Reports Third Quarter 2025 Results
October 28, 2025
From NeoGenomics, Inc.
Via Business Wire
NeoGenomics (NEO) Reports Earnings Tomorrow: What To Expect
October 26, 2025
Via StockStory
Topics Artificial Intelligence
3 Healthcare Stocks Walking a Fine Line
October 24, 2025
Via StockStory
Topics Stocks
3 Unprofitable Stocks with Open Questions
October 20, 2025
Via StockStory
Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions
October 14, 2025
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
October 14, 2025
From NeoGenomics, Inc.
Via Business Wire
NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025
October 07, 2025
From NeoGenomics, Inc.
Via Business Wire
3 Russell 2000 Stocks We Approach with Caution
October 07, 2025
Via StockStory
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know
October 02, 2025
Via StockStory
Topics World Trade
3 Cash-Burning Stocks We’re Skeptical Of
September 19, 2025
Via StockStory
NeoGenomics Stock In A Range-Bound Matrix, Weakness Likely Until 2026
September 17, 2025
Via Benzinga
Anchored at 4%: Why the Steady 10-Year Treasury Yield is Key to Unlocking the Fed's Stimulus Power
September 15, 2025
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
September 14, 2025
From Pomerantz LLP
Via GlobeNewswire

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 10.42
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 11/11/25 04:00 PM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 1.28B
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 1B shares outstanding.
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap